Transfusion of donated blood more than three weeks old results in impaired blood vessel function, a new study of hospital patients shows. Blood banks now consider six weeks to be the maximum permitted storage time of blood ...
Mar 10, 2013
1
0
Hospitals can dramatically reduce the number of life-threatening central line infections in pediatric cancer patients by following a set of basic precautions, by encouraging families to speak up when they observe noncompliance ...
Sep 3, 2012
0
0
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Sep 10, 2012
0
0
Researchers are bringing the use of acoustic waves to target and destroy cancerous tumours closer to reality.
Aug 24, 2021
0
44
An estimated 19 million new cases of cancer were diagnosed worldwide in 2020, and almost 10 million people across the globe died of the disease. This week, researchers will explore how endothelin, an amino acid chain secreted ...
Oct 4, 2021
0
24
Patches giving oestrogen through the skin could be an easy and safe alternative to the hormone therapies used to treat prostate cancer, according to new research published in the Lancet Oncology, today (Monday).
Mar 4, 2013
0
0
A growing number of patients with advanced lung cancer could soon be offered a blood test to help to decide the best treatment for them instead of having to get a tumour sample for analysis. New data from the BFAST trial ...
Sep 30, 2019
0
5
Using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient's blood to determine how well a treatment is working by the fourth week, according to a new University of Michigan study.
Jan 29, 2024
0
5
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
May 6, 2013
0
0
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
0
